LU92135I2 - Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa - Google Patents

Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa

Info

Publication number
LU92135I2
LU92135I2 LU92135C LU92135C LU92135I2 LU 92135 I2 LU92135 I2 LU 92135I2 LU 92135 C LU92135 C LU 92135C LU 92135 C LU92135 C LU 92135C LU 92135 I2 LU92135 I2 LU 92135I2
Authority
LU
Luxembourg
Prior art keywords
serogroup
canine
caused
leptospira
interrogans
Prior art date
Application number
LU92135C
Other languages
English (en)
Other versions
LU92135I9 (fr
Original Assignee
Pah Usa 15 Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35657262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92135(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pah Usa 15 Llc filed Critical Pah Usa 15 Llc
Publication of LU92135I2 publication Critical patent/LU92135I2/fr
Publication of LU92135I9 publication Critical patent/LU92135I9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
LU92135C 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa LU92135I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/959,757 US20050089533A1 (en) 2003-01-29 2004-10-06 Canine vaccines against Bordetella bronchiseptica

Publications (2)

Publication Number Publication Date
LU92135I2 true LU92135I2 (fr) 2013-03-18
LU92135I9 LU92135I9 (fr) 2019-01-04

Family

ID=35657262

Family Applications (2)

Application Number Title Priority Date Filing Date
LU92135C LU92135I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa
LU92136C LU92136I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe Australis sérovar Bratislava

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU92136C LU92136I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe Australis sérovar Bratislava

Country Status (26)

Country Link
US (2) US20050089533A1 (fr)
EP (1) EP1799253B1 (fr)
JP (2) JP4163245B2 (fr)
KR (3) KR20070050499A (fr)
CN (2) CN101791398A (fr)
AT (1) ATE524193T1 (fr)
AU (1) AU2005290921C1 (fr)
BR (1) BRPI0516253A (fr)
CA (1) CA2583689C (fr)
CY (1) CY1114897T1 (fr)
DK (1) DK1799253T3 (fr)
ES (1) ES2370750T3 (fr)
HK (1) HK1112839A1 (fr)
LU (2) LU92135I2 (fr)
ME (1) ME01306B (fr)
MX (1) MX2007004133A (fr)
NO (1) NO20071385L (fr)
NZ (3) NZ591422A (fr)
PL (1) PL1799253T3 (fr)
PT (1) PT1799253E (fr)
RS (1) RS52035B (fr)
RU (1) RU2400248C2 (fr)
SI (1) SI1799253T1 (fr)
UA (1) UA91197C2 (fr)
WO (1) WO2006038115A1 (fr)
ZA (1) ZA200702166B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110091490A1 (en) * 2000-06-30 2011-04-21 Nippon Zenyaku Kogyo Co., Ltd. Novel vaccine for dog
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
JP4667507B2 (ja) * 2005-10-07 2011-04-13 ファイザー・プロダクツ・インク イヌインフルエンザを治療するワクチンおよび方法
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2077856B1 (fr) * 2006-11-03 2015-08-12 Intervet International BV Vaccin contre la maladie de lyme canine
EP2129392B1 (fr) * 2006-12-27 2013-07-31 Zoetis P LLC Procédés d'administration de vaccin
AU2015255165A1 (en) * 2006-12-27 2015-11-26 Zoetis Services Llc Methods of vaccine administration
ES2389121T3 (es) 2007-02-27 2012-10-23 Wyeth Llc Composiciones inmunogénicas para el tratamiento y prevención de infecciones en animales
US7878586B2 (en) * 2007-10-29 2011-02-01 The Boeing Company System and method for an anticipatory passenger cabin
CN101903041A (zh) * 2007-12-21 2010-12-01 辉瑞大药厂 经热处理的菌苗,及由这些经热处理的菌苗制备的乳剂疫苗
WO2011047158A1 (fr) * 2009-10-14 2011-04-21 The Board Of Regents For Oklahoma State University Isolement d'un virus apparenté au parvovirus canin de type 2 à partir d'un raton laveur
JP5865839B2 (ja) 2010-09-28 2016-02-17 共立製薬株式会社 粘膜アジュバント組成物
DK2670432T3 (da) * 2011-02-04 2021-04-19 Zoetis Services Llc Immunogene Bordetella bronchiseptica-sammensætninger
KR20130112950A (ko) * 2011-02-04 2013-10-14 조에티스 엘엘씨 개 호흡기 복합 질환용 조성물
CN102343088B (zh) * 2011-10-14 2013-02-13 浙江诺倍威生物技术有限公司 一种犬传染性气管支气管炎二联活疫苗及其制备方法
US9480734B2 (en) 2012-08-17 2016-11-01 Intervet Inc. Immunogenic composition of killed leptospira bacteria
PT2884996T (pt) * 2012-08-17 2020-02-21 Intervet Int Bv Uma composição imunogénica de bactérias de leptospira mortas
US9314519B2 (en) * 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CZ307883B6 (cs) * 2013-01-29 2019-07-24 Bioveta, A.S. Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů
RU2546247C2 (ru) * 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
KR101622554B1 (ko) 2014-07-16 2016-05-19 (주)양성그린바이오 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법
EP3909971A1 (fr) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Vaccin de bétail à cellules entières pour maladies respiratoires
CN117187118B (zh) * 2023-08-16 2024-07-23 华中农业大学 一株支气管败血波氏杆菌a1218及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
ATE224202T1 (de) * 1993-03-31 2002-10-15 Univ California Cloniertes protein der äusseren membran von leptospira
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
AUPO549497A0 (en) * 1997-03-07 1997-03-27 Agriculture Victoria Services Pty Ltd Novel bacterial pathogens
US6306623B1 (en) * 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32
NZ501213A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
DE60222812T2 (de) * 2002-05-17 2008-08-28 Fundação Oswaldo Cruz (Fiocruz) In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen
NZ538394A (en) * 2002-08-26 2008-06-30 Pfizer Prod Inc Vaccine for respiratory and reproductive system infections in cattles
ES2303046T3 (es) * 2003-01-29 2008-08-01 Pfizer Products Inc. Vacunas caninas contra bordetella bronchiseptica.
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
EP2129392B1 (fr) * 2006-12-27 2013-07-31 Zoetis P LLC Procédés d'administration de vaccin

Also Published As

Publication number Publication date
CN101035558A (zh) 2007-09-12
RU2400248C2 (ru) 2010-09-27
AU2005290921A1 (en) 2006-04-13
NO20071385L (no) 2007-04-18
CN101035558B (zh) 2011-04-06
CA2583689A1 (fr) 2006-04-13
SI1799253T1 (sl) 2011-11-30
WO2006038115A1 (fr) 2006-04-13
PT1799253E (pt) 2011-11-10
AU2005290921C1 (en) 2012-10-11
US20080175860A1 (en) 2008-07-24
LU92136I2 (fr) 2013-03-18
CA2583689C (fr) 2013-06-11
KR20070050499A (ko) 2007-05-15
UA91197C2 (ru) 2010-07-12
CY1114897T1 (el) 2016-12-14
US20050089533A1 (en) 2005-04-28
ME01306B (me) 2013-12-20
AU2005290921B2 (en) 2010-07-08
ZA200702166B (en) 2008-11-26
BRPI0516253A (pt) 2008-08-26
PL1799253T3 (pl) 2012-01-31
JP2008239627A (ja) 2008-10-09
LU92135I9 (fr) 2019-01-04
DK1799253T3 (da) 2011-11-28
EP1799253A1 (fr) 2007-06-27
RU2007112480A (ru) 2008-11-20
HK1112839A1 (en) 2008-09-19
NZ591422A (en) 2012-09-28
ES2370750T3 (es) 2011-12-22
RS52035B (en) 2012-04-30
NZ553867A (en) 2010-10-29
KR20080096610A (ko) 2008-10-30
EP1799253B1 (fr) 2011-09-14
CN101791398A (zh) 2010-08-04
KR20120031294A (ko) 2012-04-02
KR101226869B1 (ko) 2013-01-25
JP2008515873A (ja) 2008-05-15
NZ576898A (en) 2011-03-31
ATE524193T1 (de) 2011-09-15
LU92136I9 (fr) 2019-01-04
MX2007004133A (es) 2007-06-15
JP4163245B2 (ja) 2008-10-08

Similar Documents

Publication Publication Date Title
LU92135I2 (fr) Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa
TW200505476A (en) Canine vaccines against bordetella bronchiseptica
HRP20050192B1 (hr) Cjepivo za infekcije dišnog i spolnog sustava kod goveda
AR064530A1 (es) Procedimientos para la administracion de vacunas
CA2565925A1 (fr) Vaccin pour parodontopathie
WO2004093904A3 (fr) Methodes pour prevenir les maladies genesiques des bovins
AR070675A1 (es) Bacterinas tratadas termicamente y vacunas de emulsion preparadas a partir de tales bacterinas tratadas termicamente
BRPI0407436A (pt) Composições adesivas para dentaduras, bem como método para a obtenção de efeito antiplaca
WO2008106393A3 (fr) Compositions immunogènes et procédés de traitement et de prévention d'infections chez les animaux
AR040623A1 (es) Vacuna contra el virus de la aftosa.
Gingerich et al. A parainfluenza virus 5 (PIV5)-vectored intranasal vaccine for Lyme disease provides long-lasting protection against tick transmitted Borrelia burgdorferi in mice
NZ595748A (en) Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
Gingerich et al. Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year
RU2013126074A (ru) Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
AR045152A1 (es) Vacunas virales mutantes
DOP2003000699A (es) Vacunas para enfermedades reproductoras del ganado
UA32966U (ru) Вакцина против лептоспироза животных поливалентная (вариант suis)